HISUN(SH:600267) Xin Lang Zheng Quan·2026-01-08 05:26Core Viewpoint - The stock price of Zhejiang Hai Zheng Pharmaceutical Co., Ltd. has shown a positive trend, with a year-to-date increase of 7.38% and a recent uptick in trading activity, indicating potential investor interest and market confidence in the company's performance [2]. Group 1: Stock Performance - As of January 8, the stock price increased by 2.02%, reaching 10.62 CNY per share, with a trading volume of 1.11 billion CNY and a turnover rate of 0.88%, resulting in a total market capitalization of 12.732 billion CNY [1]. - The stock has experienced a 7.49% increase over the last five trading days and a 2.02% increase over the last 20 days [2]. Group 2: Financial Performance - For the period from January to September 2025, the company reported a revenue of 7.923 billion CNY, reflecting a year-on-year growth of 0.61%, while the net profit attributable to shareholders decreased by 10.55% to 461 million CNY [2]. - Cumulative cash dividends since the company's A-share listing amount to 1.726 billion CNY, with 445 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders increased to 54,400, a rise of 5.04%, with an average of 22,041 circulating shares per shareholder, which is a decrease of 4.79% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 28.6504 million shares, an increase of 6.1171 million shares compared to the previous period [3].